Skip to main content

Dissociation between affective experience and motivated behaviour in schizophrenia patients and their unaffected first-degree relatives and schizotypal individuals

  • Dong-jie Xie (a1) (a2), Simon S. Y. Lui (a1) (a3), Fu-lei Geng (a1) (a4) (a5), Zhuo-ya Yang (a1) (a2), Ying-min Zou (a1) (a2), Ying Li (a1) (a2) (a6), Hera K. H. Yeung (a3), Eric F. C. Cheung (a3), Erin A. Heerey (a7) and Raymond C. K. Chan (a1) (a2)...

The neuropsychological origins of negative syndrome of schizophrenia remain elusive. Evidence from behavioural studies, which utilised emotion-inducing pictures to elicit motivated behaviour generally reported that that schizophrenia patients experienced similar affective experience as healthy individuals but failed to translate emotional salience to motivated behaviour, a phenomenon called emotion–behaviour decoupling. However, a few studies have examined emotion–behaviour decoupling in non-psychotic high-risk populations, who are relatively unaffected by medication effects.


In this study, we examined the nature and extent of emotion–behaviour decoupling in in three independent samples (65 schizophrenia patients v. 63 controls; 40 unaffected relatives v. 45 controls; and 32 individuals with social anhedonia v. 32 controls). We administered an experimental task to examine their affective experience and its coupling with behaviour, using emotion-inducing slides, and allowed participants to alter stimulus exposure using button-pressing to seek pleasure or avoid aversion.


Schizophrenia patients reported similar affective experiences as their controls, while their unaffected relatives and individuals with high levels of social anhedonia exhibited attenuated affective experiences, in particular in the arousal aspect. Compared with their respective control groups, all of the three groups showed emotion–behaviour decoupling.


Our findings support that both genetically and behaviourally high-risk groups exhibit emotion–behaviour decoupling. The familial association apparently supports its role as a putative trait marker for schizophrenia.

Corresponding author
*Address for correspondence: Raymond C. K. Chan, Institute of Psychology, Chinese Academy of Sciences, 16 Lincui Road, Beijing 100101, China. (E-mail:
Hide All

These two authors contributed equally to the study.

Hide All
Andreasen NC (1989). The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. British Journal of Psychiatry 7, 4958.
Berridge KC, Robinson TE (1998). What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Research Reviews 28, 309369.
Chan RCK, Wang Y, Deng Y, Zhang Y, Yiao X, Zhang C (2008). The development of a Chinese equivalence version of Letter-Number Span Test. Clinical Neuropsychologist 22, 112121.
Chan RCK, Wang Y, Huang J, Shi Y, Wang Y, Hong X, Ma Z, Li Z, Lai MK, Kring AM (2010). Anticipatory and consummatory components of the experience of pleasure in schizophrenia: cross-cultural validation and extension. Psychiatry Research 175, 181183.
Chan RCK, Wang Y, Yan C, Zhao Q, McGrath J, Hsi X, Stone WS (2012). A study of trait anhedonia in non-clinical Chinese samples: evidence from the Chapman scales for physical and social anhedonia. PLoS One 7, e34275.
Chapman LJ, Chapman JP, Raulin ML (1976). Scales for physical and social anhedonia. Journal of Abnormal Psychology 85, 374382.
Cohen AS, Callaway DA, Najolia GM, Larsen JT, Strauss GP (2012). On “risk” and reward: investigating state anhedonia in psychometrically defined schizotypy and schizophrenia. Journal of Abnormal Psychology 121, 407415.
Cohen AS, Minor KS (2010). Emotional experience in patients with schizophrenia revisited: meta-analysis of laboratory studies. Schizophrenia Bulletin 36, 143150.
Docherty AR, Sponheim SR, Kerns JG (2015). Self-reported affective traits and current affective experiences of biological relatives of people with schizophrenia. Schizophrenia Research 161, 340344.
Eckblad ML, Chapman LJ, Chapman JP, Mishlove M (1982). The Revised Social Anhedonia Scale. Unpublished test. University of Wisconsin: Madison.
Fervaha G, Grafff-Guerrero A, Zakzanis KK, Foussias G, Agid O, Remington G (2013). Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision making. Journal of Psychiatric Research 47, 15901596.
First MB, Spitzer RL, Gibbon M, Williams JBW (1996). Structured Clinical Interview for DSM-IV (SCID-I) (User's Guide and Interview) Research Version. Biometrics Research Institute, New York State Psychiatric Institute: New York.
Gard DE, Gard MG, Kring AM, John OP (2006). Anticipatory and consummatory components of the experience of pleasure: a scale development study. Journal of Research in Personality 40, 10861102.
Gard DE, Kring AM, Gard MG, Horan WP, Green MF (2007). Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophrenia Research 93, 253260.
Gard DE, Sanchez AH, Cooper K, Fisher M, Garrett C, Vinogradov S (2014). Do people with schizophrenia have difficulty anticipating pleasure, engaging in effortful behavior, or both? Journal of Abnormal Psychology 123, 771782.
Gold JM, Carpenter C, Randolph C, Goldberg TE, Weinberger DR (1997). Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Archives in General Psychiatry 54, 159165.
Gold JM, Strauss GP, Waltz JA, Robinson BM, Brown JK, Frank MJ (2013). Negative symptoms of schizophrenia are associated with abnormal effort-cost computations. Biological Psychiatry 74, 130136.
Gold JM, Waltz JA, Matveeva TM, Kasanova Z, Strauss GP, Herbener ES, Collins AGE, Frank MJ (2012). Negative symptoms and the failure to represent the expected reward value of actions. Archives of General Psychiatry 69, 129138.
Gold JM, Waltz JA, Prentice KJ, Morris SE, Heerey EA (2008). Reward processing in schizophrenia: a deficit in the representation of value. Schizophrenia Bulletin 34, 835847.
Gong YX (1992). Manual of Wechsler Adult Intelligence Scale-Chinese Version. Chinese Map Press: Changsha.
Gooding DC, Tallent KA, Matts CW (2005). Clinical status of at-risk individuals 5 years later: further validation of the psychometric high-risk strategy. Journal of Abnormal Psychology 114, 170175.
Gottesman II, Gould TD (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry 160, 636645.
Heerey EA, Gold JM (2007). Patients with schizophrenia demonstrate dissociation between affective experience and motivated behavior. Journal of Abnormal Psychology 116, 268278.
Kay SR, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261276.
Kerns JG, Docherty AR, Martin EA (2008). Social and physical anhedonia and valence and rrousal aspects of emotional experience. Journal of Abnormal Psychology 117, 735746.
Kring AM, Barch MB (2014). The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs. European Neuropsychopharmacology 24, 725736.
Kwapil TR (1998). Social anhedonia as a predictor of the development of schizophrenia-spectrum disorders. Journal of Abnormal Psychology 107, 558565.
Kwapil TR, Barrantes-Vidal N, Silvia PJ (2008). The dimensional structure of the Wisconsin schizotypy scales: factor identification and construct validity. Schizophrenia Bulletin 34, 444457.
Lenzenweger MF (2015). Thinking clearly about schizotypy: hewing to the schizophrenia liability core, considering interesting tangents, and avoiding conceptual quicksand. Schizophrenia Bulletin 41(s2), s483s491.
Lui SSY, Liu ACY, Chui WWH, Li Z, Geng F, Wang Y, Heerey EA, Cheung EFC, Chan RCK (2016 a). The nature of anhedonia and avolition in patients with first-episode schizophrenia. Psychological Medicine 46, 437447.
Lui SSY, Shi YF, Au ACW, Li Z, Tsui CF, Chan CKY, Leung MMW, Wong PTY, Wang Y, Yan C, Heerey EA, Cheung EFC, Chan RCK (2016 b). Affective experience and motivated behavior in schizophrenia spectrum disorders: evidence from clinical and non-clinical samples. Neuropsychology 30, 673684.
Marder SR, Rabinowitz J, Kapur S (2013). Clinical trials for negative symptoms – emerging directions and unresolved issues. Schizophrenia Research 150, 327327.
Mason OJ (2015). The assessment of schizotypy and its clinical relevance. Schizophrenia Bulletin 41(s2), s374s383.
McCarthy JM, Treadway MT, Blanchard JJ (2015). Motivation and effort in individuals with social anhedonia. Schizophrenia Research 165, 7075.
Meehl PE (1962). Schizotaxia, schizotypy, schizophrenia. American Psychologist 17, 827838.
Meehl PE (1989). Schizotaxia revisited. Archives of General Psychiatry 46, 935944.
Moritz S, Andreou C, Klingberg S, Thoering T, Peters MJV (2013). Assessment of subjective cognitive and emotional effects of antipsychotic drugs. Effect by defect? Neuropharmacology 72, 179186.
Raine A (1991). The SPQ – a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophrenia Bulletin 17, 555564.
Reddy LF, Horan WP, Barch DM, Buchanan RW, Dynayevich E, Gold JM, Lyons N, Marder SR, Treadway MT, Wynn JK, Young JW (2015). Effort-based decision making paradigms for clinical trials in schizophrenia: Part 1 – psychometric characteristics of 5 paradigms. Schizophrenia Bulletin 41, 10451054.
Treadway MT, Peterman JS, Zald DH, Park S (2015). Impaired effort allocation in patients with schizophrenia. Schizophrenia Research 161, 382385.
Ventura J, Subotnik KL, Gitlin MJ, Gretchen-Doorly D, Ered A, Villa KF, Hellemann GS, Nuechterlein KH (2015). Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8 years later. Schizophrenia Research 161, 407413.
Wang J, Huang J, Yang XH, Lui SSY, Cheung EFC, Chan RCK (2015). Anhedonia in schizophrenia: deficits in both motivation and hedonic capacity. Schizophrenia Research 168, 465474.
Wang K, Shi HS, Geng FL, Zou LQ, Tan SP, Wang Y, Neumann DL, Shum DH, Chan RC (2016). Cross-cultural validation of the depression anxiety stress scale-21 in China. Psychological Assessment 28, 88100.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Type Description Title
Supplementary materials

Xie et al supplementary material
Xie et al supplementary material 1

 Word (29 KB)
29 KB


Altmetric attention score

Full text views

Total number of HTML views: 2
Total number of PDF views: 30 *
Loading metrics...

Abstract views

Total abstract views: 137 *
Loading metrics...

* Views captured on Cambridge Core between 11th October 2017 - 15th December 2017. This data will be updated every 24 hours.